VOR
Price:
$0.7973
Market Cap:
$54.53M
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
VOR
According to Vor Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.28M. This represents a change of -89.25% compared to the average of 114.18M of the last 4 quarters.
The mean historical Enterprise Value of Vor Biopharma Inc. over the last ten years is 615.54M. The current 12.28M Enterprise Value has changed 99.47% with respect to the historical average. Over the past ten years (40 quarters), VOR's Enterprise Value was at its highest in in the December 2020 quarter at 804.65M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
615.54M
Median
287.20M
Minimum
155.48M
Maximum
1.39B
Discovering the peaks and valleys of Vor Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 542.05%
Maximum Annual Enterprise Value = 1.39B
Minimum Annual Increase = -75.76%
Minimum Annual Enterprise Value = 155.48M
Year | Enterprise Value | Change |
---|---|---|
2023 | 155.48M | -36.34% |
2022 | 244.22M | -26.03% |
2021 | 330.18M | -75.76% |
2020 | 1.36B | -1.70% |
2019 | 1.39B | 542.05% |
The current Enterprise Value of Vor Biopharma Inc. (VOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
243.30M
5-year avg
695.49M
10-year avg
615.54M
Vor Biopharma Inc.’s Enterprise Value is less than Gracell Biotechnologies Inc. (5.47B), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Monte Rosa Therapeutics, Inc. (481.73M), less than Design Therapeutics, Inc. (257.66M), less than Erasca, Inc. (687.71M), less than Edgewise Therapeutics, Inc. (3.20B), less than Talaris Therapeutics, Inc. (50.00M), greater than Adicet Bio, Inc. (-99463720.00), less than Cullinan Oncology, Inc. (814.18M), less than Nuvalent, Inc. (6.14B), less than Ventyx Biosciences, Inc. (122.28M), less than Arcellx, Inc. (4.68B), less than Kiniksa Pharmaceuticals, Ltd. (1.47B), less than Bolt Biotherapeutics, Inc. (37.87M), less than Day One Biopharmaceuticals, Inc. (1.08B), less than Lyra Therapeutics, Inc. (21.96M), less than Autolus Therapeutics plc (482.29M), less than Foghorn Therapeutics Inc. (355.11M), greater than Shattuck Labs, Inc. (-2464878.00), less than Kymera Therapeutics, Inc. (3.06B), less than Nurix Therapeutics, Inc. (1.71B),
Company | Enterprise Value | Market cap |
---|---|---|
5.47B | $989.87M | |
138.26M | $181.50M | |
481.73M | $546.22M | |
257.66M | $300.65M | |
687.71M | $806.55M | |
3.20B | $3.24B | |
50.00M | $116.44M | |
-99463720.00 | $105.47M | |
814.18M | $926.47M | |
6.14B | $6.22B | |
122.28M | $151.94M | |
4.68B | $4.70B | |
1.47B | $1.56B | |
37.87M | $25.18M | |
1.08B | $1.50B | |
21.96M | $17.12M | |
482.29M | $900.56M | |
355.11M | $453.14M | |
-2464878.00 | $54.41M | |
3.06B | $3.09B | |
1.71B | $1.78B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vor Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vor Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vor Biopharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vor Biopharma Inc. (VOR)?
What is the 3-year average Enterprise Value for Vor Biopharma Inc. (VOR)?
What is the 5-year average Enterprise Value for Vor Biopharma Inc. (VOR)?
How does the current Enterprise Value for Vor Biopharma Inc. (VOR) compare to its historical average?